Bliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publication
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bliss GVS Pharma has informed the stock exchanges (NSE and BSE) that it published a notice in newspapers on April 4, 2026, as required under SEBI Listing Regulations. The notice informs shareholders about an extended special window to re-lodge transfer requests for physical shares that were originally submitted before April 1, 2019 but were rejected or returned due to document deficiencies. The advertisements appeared in Economic Times and Free Press Journal (English) and Maharashtra Times and Navshakti (regional language). Shareholders must ensure they have an active demat account, as re-lodged shares will be transferred only in demat form. Eligible shareholders are asked to contact the company's Registrar and Transfer Agent, MUFG Investor Services India Pvt Ltd (formerly Karvy Fintech), before the deadline of February 2026.
This is a routine regulatory compliance disclosure with no direct impact on stock price or financials. Shareholders holding physical share certificates who had earlier transfer requests rejected now have an additional opportunity to get their shares transferred into demat accounts.